De Gottardi, Andrea; Garcia-Pagan, Juan Carlos (2017). The anticoagulant efficacy of rivaroxaban may be attenuated in cirrhotic patients. Liver international, 37(8), p. 1252. Wiley 10.1111/liv.13420
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Gottardi_et_al-2017-Liver_International(1).pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (158kB) | Request a copy |
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie 04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology |
UniBE Contributor: |
De Gottardi, Andrea |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1478-3231 |
Publisher: |
Wiley |
Language: |
English |
Submitter: |
Thi Thao Anh Pham |
Date Deposited: |
31 Jan 2018 16:33 |
Last Modified: |
05 Dec 2022 15:09 |
Publisher DOI: |
10.1111/liv.13420 |
PubMed ID: |
28710817 |
BORIS DOI: |
10.7892/boris.109508 |
URI: |
https://boris.unibe.ch/id/eprint/109508 |
Actions (login required)
 |
Edit item |